LevLane Advertising and Rosy Wellness Release Women's Health White Paper: "The Women Are Not Alright"
20 juin 2024 10h00 HE
|
LevLane
PHILADELPHIA, June 20, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent, full-service advertising agencies, and Rosy Wellness, the Webby Award-winning...
LevLane Advertising Wins PRSA Anvil Award for Best Feature Article Addressing Bias Against Use of Biological Terms in Women's Health Marketing and Advertising
28 mai 2024 08h00 HE
|
LevLane
PHILADELPHIA, May 28, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, was awarded an Anvil Award for the prestigious...
Frontier Nursing University and Campion Fund to Host Maternal Mortality Conference
22 mai 2024 08h09 HE
|
Frontier Nursing University
Versailles, Ky, May 22, 2024 (GLOBE NEWSWIRE) -- Frontier Nursing University (FNU) and the Campion Fund announced plans for a conference focused on the nation’s maternal mortality crisis. “Reducing...
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
21 mai 2024 08h00 HE
|
Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 21, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
19 mai 2024 20h00 HE
|
Amplexd Therapeutics Inc.
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible...
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15 mai 2024 16h10 HE
|
Agile Therapeutics, Inc.
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15,...
3Daughters Announces Three New Appointments to Board of Directors
13 mars 2024 08h00 HE
|
3Daughters
MANSFIELD, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- 3Daughters, a clinical development company fueling evolutionary healthcare for women, announced the appointment of Michele LaRussa, Vincent J....
BioAdaptives, Inc. Commences Development of a New Supplement for Women’s Health
05 oct. 2023 08h00 HE
|
BioAdaptives, Inc.
PluriPain®-PMS is an Advanced Derivative of the Company’s Popular Supplement, PluriPain® LAS VEGAS, NV, Oct. 05, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTC: BDPT), a...
ABOG Appoints Amy Young, MD, as Next Executive Director
14 juin 2023 12h43 HE
|
American Board of Obstetrics and Gynecology
Dallas, Texas, June 14, 2023 (GLOBE NEWSWIRE) -- The American Board of Obstetrics and Gynecology (ABOG) is pleased to announce the appointment of Amy Young, MD, as its new Executive Director,...
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
08 juin 2023 09h00 HE
|
ResMed Inc.
The studies also showed 18-40% lower costs incurred from ER visits and hospitalizations after 1 year for PAP-adherent OSA patients with diastolic and systolic heart failure, respectivelyA third study...